Ani Javadian1, Eisa Salehi1, Katayon Bidad2, Mohammad Ali Sahraian3, Maryam Izad4. 1. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Iran. 2. Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Iran. 3. MS Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran. 4. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Iran. Electronic address: izadm@sina.tums.ac.ir.
Abstract
BACKGROUND AND AIMS: A large body of studies has shown that 17-β estradiol (E2) has a protective effect on susceptibility to experimental autoimmune encephalomyelitis (EAE). Clinical improvement in multiple sclerosis and its animal model, EAE, during pregnancy, when estrogen levels are high, suggests an immunomodulatory role for estrogens. The immune basis for this protection is poorly understood. In this study we evaluated the effect of E2 on the synthesis of inflammatory, antiinflammatory and regulatory cytokines. METHODS: We analyzed the effect of E2 on IL-4, IL-10, IL-17, TNF-α and IFN-γ cytokines produced by proteolipid protein (PLP) or mitogen phytohemagglutinin (PHA)-activated peripheral blood mononuclear cells isolated from multiple sclerosis patients in comparison to healthy control group. We used RT-PCR and ELISA to detect the level of cytokines. RESULTS: We found that E2 significantly increased IL-10 expression and secretion and decreased expression of TNF-α in both groups and IL-4 in patients in cells stimulated with PLP or PHA (p <0.0001). CONCLUSION: These data indicated that E2 could affect expression and secretion of inflammatory and anti-inflammatory cytokines and could regulate immune responses especially in the differentiation towards regulatory responses, and this finding might have therapeutic value in multiple sclerosis.
BACKGROUND AND AIMS: A large body of studies has shown that 17-β estradiol (E2) has a protective effect on susceptibility to experimental autoimmune encephalomyelitis (EAE). Clinical improvement in multiple sclerosis and its animal model, EAE, during pregnancy, when estrogen levels are high, suggests an immunomodulatory role for estrogens. The immune basis for this protection is poorly understood. In this study we evaluated the effect of E2 on the synthesis of inflammatory, antiinflammatory and regulatory cytokines. METHODS: We analyzed the effect of E2 on IL-4, IL-10, IL-17, TNF-α and IFN-γ cytokines produced by proteolipid protein (PLP) or mitogen phytohemagglutinin (PHA)-activated peripheral blood mononuclear cells isolated from multiple sclerosispatients in comparison to healthy control group. We used RT-PCR and ELISA to detect the level of cytokines. RESULTS: We found that E2 significantly increased IL-10 expression and secretion and decreased expression of TNF-α in both groups and IL-4 in patients in cells stimulated with PLP or PHA (p <0.0001). CONCLUSION: These data indicated that E2 could affect expression and secretion of inflammatory and anti-inflammatory cytokines and could regulate immune responses especially in the differentiation towards regulatory responses, and this finding might have therapeutic value in multiple sclerosis.
Authors: Qi Chen; Siji Nian; Yingchun Ye; Dan Liu; Hong Yu; Hong Xiong; Bi Pan; Lu Xiao; Chunrong Fan; Qing Yuan Journal: Inflammation Date: 2021-11-26 Impact factor: 4.092
Authors: Laura S Peterson; Ina A Stelzer; Amy S Tsai; Mohammad S Ghaemi; Xiaoyuan Han; Kazuo Ando; Virginia D Winn; Nadine R Martinez; Kevin Contrepois; Mira N Moufarrej; Stephen Quake; David A Relman; Michael P Snyder; Gary M Shaw; David K Stevenson; Ronald J Wong; Petra Arck; Martin S Angst; Nima Aghaeepour; Brice Gaudilliere Journal: Semin Immunopathol Date: 2020-02-04 Impact factor: 9.623
Authors: Forayssa M Talaat; Noha T Abokrysha; Dalia M Labib; Engy El Khateeb; Ghada Hatem Abd El Aziz Journal: Egypt J Neurol Psychiatr Neurosurg Date: 2018-11-03